/PRNewswire/ GenScript USA Inc., the world s leading life-science research tools and services provider, announced its third annual GenScript Gene & Cell.
Free, one-day online event features life-science leaders from academia, pharma, and biotech who are leveraging the strengths of synthetic biology technologies to develop life-changing.
November 18th, 2022. Today, Applied Cells Inc. and GenScript USA Incorporated announced their strategic collaboration to deliver combined cell isolation solutions for cell therapy drug development worldwide. Under this collaboration, GenScript will develop and supply its proprietary research and cGMP grade CytoSinct™ reagents for use in developing CAR-T and other Cell Therapy products on the Applied Cells MARS® Platform.
/PRNewswire/ Today, Applied Cells Inc. and GenScript USA Incorporated announced their strategic collaboration to deliver combined cell isolation solutions.